Colfosceril Palmitate

Drug #1700

Colfosceril Palmitate is a phospholipid which forms an important constituent of endogenous pulmonary surfactant compounds.

← Previous drug Next drug →

Primary Characteristics

It is of Synthetic origin.

Molecular Weight: 734.39 · Non-proprietary name: Colfosceril Palmitate.

Molecular structure of Colfosceril Palmitate

Pharmacokinetics

Elimination: it is metabolised via catabolized & reutilized.

Indications

Colfosceril Palmitate is primarily indicated in conditions like Respiratory distress syndrome.

Contraindications

Colfosceril Palmitate is contraindicated in conditions like Hypersensitivity to any component of product.

Dosage

Colfosceril Palmitate's dosage details are as follows:

Dose	Single Dose	Frequency	Route	Instructions
Adult Dosage
5 ml/kg	5 ml/kg	—	IV	Prophylactic treatment: 1st dose should be given after birth and 2nd and 3rd dose is given 12 and 24 hours later to infants.
Paediatric Dosage (20kg)
No data.
Neonatal Dosage (3kg)
No data.

Drug Interactions

None recorded.

Side Effects

Colfosceril Palmitate is known to cause more or less tolerable side effects which are usually transient. These include Obstruction of the endotracheal tube by mucous secretions, Pulmonary hemorrhage.

Warnings / Precautions

Continuous monitoring is required to avoid hyperoxaemia (due to rapid improvement in arterial oxygen concentration)

Available Brands

Click on a strength to view available brands.

Single Ingredient

Inj

108 mg

Storage Conditions

Colfosceril Palmitate should be stored .

Drug Classification

1.25.6 — Respiratory stimulants and pulmonary surfactants

Manufacturers

Manufacturers of Colfosceril Palmitate in Pakistan:

GSK